gentamicin has been researched along with daptomycin in 83 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (7.23) | 18.7374 |
1990's | 9 (10.84) | 18.2507 |
2000's | 28 (33.73) | 29.6817 |
2010's | 33 (39.76) | 24.3611 |
2020's | 7 (8.43) | 2.80 |
Authors | Studies |
---|---|
Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C | 1 |
Bayer, AS; Eliopoulos, GM; Grayson, ML; Ramos, MC | 1 |
Carbon, C; Caron, F; Cremieux, AC; Gutmann, L; Kitzis, MD; Lemeland, JF; Maziere, B; Saleh-Mghir, A; Vallois, JM | 1 |
Bingen, E; Courvalin, P; Duval, J; Lambert-Zechovski, N; Leclercq, R; Su, QH | 1 |
Gristina, A; Myrvik, QN; Naylor, PT | 1 |
Eliopoulos, GM; Moellering, RC; Rice, LB | 1 |
Chandrasekar, PH; Sluchak, JA | 1 |
Andriole, VT; Johnson, MA; Miniter, PM; Patterson, TF | 1 |
Canawati, HN; Ginunas, VJ; Montgomerie, JZ; Sapico, FL | 1 |
Ehlert, F; Neu, HC | 1 |
Watanakunakorn, C | 1 |
Beauchamp, D; Bergeron, MG; Carrier, D; Couture, M; Gurnani, K; Khouri, H | 1 |
Beauchamp, D; Bergeron, MG; Grenier, L; Simard, M; Thibault, N | 2 |
Bou Khalil, M; Carrier, D; Kealey, A | 1 |
Akins, RL; Rybak, MJ | 1 |
LaPlante, KL; Rybak, MJ | 1 |
Rybak, MJ; Tsuji, BT | 1 |
Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
Abrutyn, E; Bernstein, JM; Boucher, HW; Brodt, HR; Cabell, CH; Chambers, HF; Cook, P; Corey, GR; Cosgrove, SE; DeMeyer, I; Fätkenheuer, G; Filler, SG; Forrest, GN; Fowler, VG; Gareca, M; Karchmer, AW; Levine, DP; Link, AS; Parsonnet, J; Price, CS; Rehm, SJ; Rupp, ME; Tally, FP; Tice, A; Vigliani, GA; Zervos, M | 1 |
Brown, KR; Edmiston, CE; Goheen, MP; Johnson, CP; Lewis, BD; Seabrook, GR; Towne, JB | 1 |
DeRyke, CA; Kuti, JL; Nicolau, DP; Sutherland, C; Zhang, B | 1 |
Appelbaum, PC; Credito, K; Lin, G | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Federspiel, JJ; Fowler, VG; Kanafani, ZA | 1 |
Barber, GR; Lauretta, J; Saez, R | 1 |
Alder, JD; Mascio, CT; Silverman, JA | 1 |
Arias, CA; Moore, J; Murray, BE; Panesso, D; Singh, KV; Torres, HA; Wanger, A | 1 |
Baltch, AL; Bopp, LH; Michelsen, P; Ritz, WJ; Smith, RP | 1 |
Leonard, SN; Rose, WE; Rybak, MJ | 1 |
Abrutyn, E; Boucher, H; Campion, M; Corey, GR; Eisenstein, BI; Levine, D; Rehm, SJ; Vigliani, GA | 1 |
Evans, RP; Haggard, WO; McLaren, SG; Smeltzer, MS; Weiss, BD; Weiss, EC | 1 |
Boutoille, D; Corvec, S; Frioux, R; Grossi, O; Raffi, F; Talarmin, JP | 1 |
Beltrand, E; Fayad, G; Legout, L; Leroy, O; Senneville, E | 1 |
Bookstaver, PB; Raad, II; Sherertz, RJ; Tucker, BK; Williamson, JC | 1 |
Abrutyn, E; Boucher, HW; Chambers, HF; Corey, GR; Cosgrove, SE; Fowler, VG; Karchmer, AW; Levine, DP; Rupp, ME; Vigliani, GA | 1 |
Arav-Boger, R; Carroll, KC; Jacobson, LM; Milstone, AM; Zenilman, J | 1 |
LaPlante, KL; Woodmansee, S | 1 |
Almela, M; Armero, Y; del Río, A; García-de-la-Mària, C; Gatell, JM; Jiménez de Anta, MT; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Sarasa, M; Soy, D | 1 |
Ambrose, PG; Bhavnani, SM; Hammel, JP; Prakhya, A | 1 |
Bruss, JB | 1 |
Boucher, HW; Campion, M; Corey, GR; Fowler, VG; Kanafani, ZA; Katz, DE; Kourany, WM; Levine, DP; Vigliani, GA | 1 |
Mohr, JF; Steenbergen, JN; Thorne, GM | 1 |
Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Garazzino, S; Michelazzo, M; Sciandra, M; Siccardi, M; Simiele, M; Ventimiglia, G | 1 |
Brown-Driver, V; Conrad, M; Finn, J; G C, K; Haselbeck, RJ; Rubio, A; Silverman, JA | 1 |
Erbel, R; Plicht, B | 1 |
Bookstaver, PB; Hashem, MG; Iqbal, R; James, CL; Le, J; Rudisill, CN; Sakoulas, G | 1 |
Fitzgibbons, LN; Forrest, GN; Mackay, K; Puls, DL | 1 |
Bayer, AS; Chen, L; Kreiswirth, BN; McKinnell, J; Mishra, NN; Nast, CC; Rubio, A; Yeaman, MR | 1 |
Betrisey, B; Corvec, S; Furustrand Tafin, U; Majic, I; Trampuz, A; Zalila Belkhodja, C; Zimmerli, W | 1 |
Akid, R; Banerjee, RD; Dodds, S; Nichol, T; Smith, TJ; Stephenson, J; Stockley, I; Townsend, R | 1 |
Davis-Boozer, D; Feiz, V; Li, J; Polage, C; Vieira, AC | 1 |
Becker, K; Denis, O; Garcia, LG; Kahl, BC; Lemaire, S; Proctor, RA; Tulkens, PM; Van Bambeke, F | 1 |
Ozcimen, M; Sakarya, R; Sakarya, Y | 1 |
Cortes, NJ; Koziol, L; Lloyd, JM; O'Hara, L | 1 |
Awrey, D; Bardouniotis, E; Berman, J; Hafkin, B; Kaplan, N; Pauls, HW; Yethon, J | 1 |
Almela, M; Armero, Y; Castañeda, X; Cervera, C; Del Río, A; Espinal, PA; Falces, C; García-de-la-Mària, C; Gatell, JM; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Ninot, S; Pericas, JM; Soy, D; Vila, J; Vila-Farrés, X | 1 |
Couet, W; Gobin, P; Lauda, M; Le Moal, G; Marchand, S; Roblot, F | 1 |
Crum-Cianflone, N; Haddad, F; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G | 1 |
Bertram, R; Götz, F; Leibig, M; Ohlsen, K; Schäfer, T; Yu, W | 1 |
Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
Andreacchio, KA; Cárdenas, AM; Edelstein, PH | 1 |
Arvanitis, M; LaPlante, KL; Luther, MK; Mylonakis, E | 1 |
Bétrisey, B; Borens, O; Furustrand Tafin, U; Peñalba Arias, P; Trampuz, A; Vogt, S | 1 |
Carvalho, M; Charlton, CL; Hindler, JA; Humphries, R; Kelesidis, T; Miller, SA; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Wong-Beringer, A | 1 |
Coronado-Álvarez, NM; Hernández-Quero, J; Parra, D; Parra-Ruiz, J; Peña-Monje, A | 1 |
Endimiani, A; Furrer, H; Hirzberger, L; Hirzel, C | 1 |
Desai, S; Nair, S; Poonacha, N; Sharma, U; Vipra, A | 1 |
Arias, CA; Bayer, AS; Garcia de la Maria, C; Miró, JM; Mishra, NN; Rice, S; Rybak, MJ; Singh, NB; Smith, JR; Stamper, K; Sullam, P; Tran, TT; Yim, J | 1 |
Aktas, G; Derbentli, S | 1 |
Di Luca, M; Gonzalez Moreno, M; Trampuz, A | 1 |
Breusch, SJ; Dall, GF; Gallagher, MP; Gwynne, PJ; MacKenzie, SP; Simpson, AHRW; Tsang, SJ | 1 |
Alvarez, DN; Bayer, AS; Farah, S; Garcia-de-la-Maria, C; Miro, JM; Mishra, NN; Sakoulas, G; Zapata, B | 1 |
Bowker, KE; Lovering, AM; MacGowan, AP; Nelson, SM; Sweeney, E | 1 |
Chang, SC; Chen, PY; Lee, YC; Wang, JT | 1 |
Galanter, KM; Ho, J | 1 |
Kılınç, S; Pazarcı, Ö; Sümer, Z; Tunç, T | 1 |
Almela, M; Ambrosioni, J; Cañas, MA; Castañeda, X; Falces, C; Fuster, D; García-de-la-Mària, C; García-González, J; Gasch, O; Hernández-Meneses, M; Llopis, J; Marco, F; Miró, JM; Moreno, A; Pericàs, JM; Quintana, E; Sandoval, E; Soy, D; Téllez, A; Tolosana, JM; Vidal, B | 1 |
Huang, M; Johnson, TM; Kiser, TH; Miller, MA; Molina, KC; Mueller, SW | 1 |
Grinholc, M; Kruszewska, B; Pierański, MK; Rychłowski, M; Woźniak, A | 1 |
Gayathri, K; Mahalakshmi, K; Mitthra, S; Padmavathy, K; Subbiya, A; Venkatesh, A | 1 |
Russo, A; Venditti, M | 1 |
Cunningham, SA; Patel, R; Vaillant, JJ | 1 |
1 review(s) available for gentamicin and daptomycin
Article | Year |
---|---|
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Gentamicins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Rifampin | 2009 |
5 trial(s) available for gentamicin and daptomycin
Article | Year |
---|---|
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Methicillin Resistance; Middle Aged; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cross-Over Studies; Daptomycin; Drug Interactions; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Serum Bactericidal Test; Staphylococcus aureus | 2006 |
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2008 |
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Creatinine; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Penicillins; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Young Adult | 2009 |
Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Diabetes Complications; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin | 2009 |
77 other study(ies) available for gentamicin and daptomycin
Article | Year |
---|---|
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Peptides; Rats; Teicoplanin; Vancomycin | 1992 |
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Rabbits; Vancomycin | 1992 |
Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Daptomycin; Diffusion; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus; Female; Gentamicins; Glycopeptides; Humans; Microbial Sensitivity Tests; Peptides; Rabbits; Teicoplanin | 1992 |
Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Glycopeptides; Peptides; Streptococcus; Time Factors | 1991 |
Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biocompatible Materials; Cefazolin; Coagulase; Daptomycin; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Nafcillin; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1990 |
In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Drug Synergism; Enterococcus faecalis; Fosfomycin; Gentamicins; Microbial Sensitivity Tests; Peptides; Peptidoglycan | 1989 |
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Species Specificity; Staphylococcus aureus | 1989 |
Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Drug Synergism; Enterococcus faecalis; Female; Gentamicins; Microbial Sensitivity Tests; Peptides; Pyelonephritis; Rats; Rats, Inbred Strains; Streptococcal Infections; Time Factors | 1987 |
LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Male; Microbial Sensitivity Tests; Peptides; Pyelonephritis; Random Allocation; Rats; Rats, Inbred Strains; Streptococcal Infections; Vancomycin | 1988 |
In vitro activity of LY146032 (daptomycin), a new peptolide.
Topics: Anti-Bacterial Agents; Bacteria; Corynebacterium; Daptomycin; Drug Synergism; Gentamicins; Listeria monocytogenes; Microbial Sensitivity Tests; Peptides; Staphylococcus; Streptococcus | 1987 |
In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococci.
Topics: Anti-Bacterial Agents; Bacteria; Daptomycin; Drug Synergism; Gentamicins; Microbial Sensitivity Tests; Peptides; Tobramycin | 1987 |
Molecular basis of the inhibition of gentamicin nephrotoxicity by daptomycin; an infrared spectroscopic investigation.
Topics: Amino Acid Sequence; Daptomycin; Drug Interactions; Gentamicins; Humans; Kidney Diseases; Liposomes; Molecular Sequence Data; Phosphatidylinositols; Spectroscopy, Fourier Transform Infrared | 1995 |
Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats.
Topics: Animals; Creatinine; Daptomycin; Female; Gentamicins; Kidney Cortex; Kidney Diseases; Kidney Tubules, Proximal; Lysosomes; Microscopy, Immunoelectron; Nephrectomy; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase | 1995 |
Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity.
Topics: Animals; Creatinine; Daptomycin; DNA; Female; Gentamicins; Immunohistochemistry; Kidney; Kidney Cortex; Kidney Diseases; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase; Subcellular Fractions; Thymidine | 1994 |
Modulation of phospholipase A2 activity by aminoglycosides and daptomycin: a Fourier transform infrared spectroscopic study.
Topics: Aminoglycosides; Animals; Daptomycin; Drug Synergism; Elapid Venoms; Gentamicins; Hydrolysis; Lipid Bilayers; Liposomes; Phospholipases A; Phospholipases A2; Spectroscopy, Fourier Transform Infrared | 1998 |
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Culture Media; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Half-Life; Kinetics; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillins; Staphylococcus aureus; Vancomycin | 2004 |
Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Culture Media; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin | 2005 |
Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcus aureus | 2005 |
Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Blood Vessel Prosthesis; Ceftriaxone; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus; Vancomycin | 2006 |
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Time Factors | 2007 |
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Monocytes; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 2007 |
Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Humans; Middle Aged | 2007 |
A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus; Female; Fever; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Neutropenia | 2007 |
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Cell Division; Ciprofloxacin; Daptomycin; Erythromycin; Gentamicins; Hydrazones; Microbial Sensitivity Tests; Nafcillin; Staphylococcus aureus; Vancomycin | 2007 |
Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multigene Family; Treatment Failure; Vancomycin Resistance | 2007 |
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
Topics: Anti-Bacterial Agents; Cells, Cultured; Daptomycin; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcus aureus | 2008 |
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Culture Media; Daptomycin; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2008 |
Optimized elution of daptomycin from polymethylmethacrylate beads.
Topics: Bone Cements; Chemistry, Pharmaceutical; Daptomycin; Drug Carriers; Gentamicins; Polymethyl Methacrylate; Vancomycin; Xylitol | 2009 |
[Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
Topics: Acetamides; Aged, 80 and over; Anesthesia; Anti-Bacterial Agents; Bacteremia; Bone Marrow Diseases; Comorbidity; Contraindications; Daptomycin; Drug Administration Schedule; Drug Therapy, Combination; Gentamicins; Hip Prosthesis; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Systemic Inflammatory Response Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
[Treatment of mitral MRSA endocarditis using daptomycin].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Combined Modality Therapy; Daptomycin; Device Removal; Drug Therapy, Combination; Endocarditis, Bacterial; Fatal Outcome; Female; Gentamicins; Hip Prosthesis; Humans; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Postoperative Complications; Prosthesis-Related Infections; Respiratory Distress Syndrome; Rifampin; Staphylococcal Infections; Thrombocytopenia; Vancomycin | 2008 |
Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections.
Topics: Anti-Bacterial Agents; Anticoagulants; Catheter-Related Infections; Catheterization, Central Venous; Colony Count, Microbial; Daptomycin; Drug Therapy, Combination; Gentamicins; Humans; In Vitro Techniques; Isotonic Solutions; Minocycline; Models, Theoretical; Tigecycline | 2009 |
Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Therapy, Combination; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2009 |
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Endocarditis; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2009 |
Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Endocarditis, Bacterial; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits | 2009 |
Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Costs and Cost Analysis; Daptomycin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2009 |
Lack of evidence associating nephrotoxicity with low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis.
Topics: Anti-Bacterial Agents; Bacteremia; Creatinine; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Kidney; Sample Size; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2009 |
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Daptomycin; Gentamicins; Humans; Limit of Detection; Rifampin | 2010 |
Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Northern; Daptomycin; Drug Resistance, Bacterial; Gentamicins; Microbial Sensitivity Tests; RNA, Antisense; Staphylococcus aureus; Vancomycin | 2011 |
[Diagnosis and treatment of infective endocarditis. Current ESC guidelines].
Topics: Anti-Bacterial Agents; Bacteremia; Cardiac Surgical Procedures; Combined Modality Therapy; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Three-Dimensional; Echocardiography, Transesophageal; Endocarditis, Bacterial; Europe; Gentamicins; Heart Defects, Congenital; Heart Valve Prosthesis Implantation; Humans; Methicillin-Resistant Staphylococcus aureus; Postoperative Complications; Secondary Prevention; Staphylococcal Infections; Vancomycin Resistance | 2010 |
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Topics: Acetamides; Aged; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2010 |
Management of gram-positive coccal bacteremia and hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Kidney Failure, Chronic; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Renal Dialysis; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2011 |
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
Topics: alpha-Defensins; Antimicrobial Cationic Peptides; beta-Thromboglobulin; Daptomycin; Genotype; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Polymyxin B; Vancomycin | 2011 |
Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Vancomycin | 2011 |
Contrasting effects of physical wear on elution of two antibiotics from orthopedic cement.
Topics: Acetates; Anti-Bacterial Agents; Arthroplasty; Biomimetics; Bone Cements; Buffers; Crystallization; Daptomycin; Diffusion; Gentamicins; Humans; Kinetics; Microscopy, Electron, Scanning; Vancomycin | 2012 |
The safety and efficacy of linezolid and daptomycin as an additive in Optisol-GS against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Daptomycin; Dextrans; Drug Stability; Drug Therapy, Combination; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Oxazolidinones; Pilot Projects; Staphylococcal Infections; Treatment Outcome | 2012 |
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.
Topics: Anti-Bacterial Agents; Cell Line; Daptomycin; Gentamicins; Glycopeptides; Hemin; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitamin K 3 | 2012 |
The safety and efficacy of linezolid and daptomycin as an additive in optisol-GS against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Chondroitin Sulfates; Daptomycin; Dextrans; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Organ Preservation Solutions; Oxazolidinones | 2012 |
Successful clinical use of daptomycin-impregnated bone cement in two-stage revision hip surgery for prosthetic joint infection.
Topics: Aged; Anti-Bacterial Agents; Bone Cements; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Hip Prosthesis; Humans; Polymethyl Methacrylate; Prosthesis-Related Infections; Recurrence; Reoperation; Treatment Outcome | 2013 |
In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics.
Topics: Animals; Anti-Bacterial Agents; Benzofurans; Blood Proteins; Daptomycin; Dogs; Gentamicins; Half-Life; Humans; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Pulmonary Surfactants; Pyrones; Rats; Staphylococcal Infections; Staphylococcus aureus | 2013 |
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Rabbits; Species Specificity; Streptococcal Infections; Streptococcus anginosus; Streptococcus bovis; Streptococcus mitis; Streptococcus mutans; Vancomycin | 2013 |
Pharmacokinetics of daptomycin in a patient with severe renal failure not receiving dialysis.
Topics: Anti-Bacterial Agents; Daptomycin; Female; Gentamicins; Humans; Middle Aged; Renal Dialysis; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Ceftaroline; Cell Membrane; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2013 |
The mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colony Count, Microbial; Daptomycin; Gene Deletion; Genetic Complementation Test; Gentamicins; Ligases; Mevalonic Acid; Microbial Sensitivity Tests; Polyisoprenyl Phosphates; Rifampin; Staphylococcus aureus | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Prevalence and detection of mixed-population enterococcal bacteremia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Coinfection; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Multilocus Sequence Typing; Oxazolidinones; Prevalence; Treatment Outcome; Vancomycin Resistance | 2014 |
Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Gal
Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Daptomycin; Drug Interactions; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Humans; Larva; Linezolid; Microbial Sensitivity Tests; Models, Biological; Models, Statistical; Moths; Oxazolidinones; Rifampin | 2014 |
Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Bone and Bones; Bone Cements; Daptomycin; Gentamicins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Polyethylene Glycols; Polymethyl Methacrylate; Prosthesis-Related Infections; Staphylococcus epidermidis | 2015 |
In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Daptomycin; DNA Mutational Analysis; DNA, Bacterial; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enterococcus faecium; Ertapenem; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Vancomycin Resistance | 2015 |
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.
Topics: Anti-Bacterial Agents; Biofilms; Catheters; Clarithromycin; Daptomycin; Drug Therapy, Combination; Ethanol; Gentamicins; Humans; In Vitro Techniques; Isotonic Solutions; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 2015 |
Bactericidal activity of penicillin, ceftriaxone, gentamicin and daptomycin alone and in combination against Aerococcus urinae.
Topics: Aerococcus; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Colony Count, Microbial; Daptomycin; Drug Synergism; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Time Factors | 2016 |
Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Daptomycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Recombinant Fusion Proteins; Staphylococcus aureus; Vancomycin | 2016 |
Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
Topics: Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Therapy, Combination; Endocarditis; Gentamicins; Humans; Models, Biological; Streptococcal Infections; Streptococcus mitis; Treatment Outcome | 2017 |
In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections | 2017 |
Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis.
Topics: Anti-Bacterial Agents; Biofilms; Calorimetry; Daptomycin; Fosfomycin; Gentamicins; Humans; Microbial Sensitivity Tests; Microbial Viability; Plankton; Streptococcal Infections; Streptococcus agalactiae; Streptococcus oralis; Streptococcus pyogenes | 2017 |
Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Drug Antagonism; Drug Synergism; Gentamicins; Humans; Joint Prosthesis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 2018 |
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Combinations; Drug Resistance, Bacterial; Gentamicins; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Rifampin; Streptococcus mitis; Streptococcus oralis; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
An in vitro biofilm model of Staphylococcus aureus infection of bone.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cattle; Daptomycin; Disease Models, Animal; Femur; Gentamicins; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2019 |
A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Fosfomycin; Gentamicins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin | 2019 |
Treatment of tricuspid valve endocarditis with daptomycin and linezolid therapy.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Substitution; Drug Synergism; Endocarditis, Bacterial; Female; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome; Tricuspid Valve; Vancomycin | 2019 |
Research into biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin antibiotics at common doses added to bone cement.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Cells, Cultured; Cytotoxicity Tests, Immunologic; Daptomycin; Dose-Response Relationship, Drug; Gentamicins; Materials Testing; Mice; Teaching Materials; Teicoplanin; Vancomycin | 2020 |
Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cloxacillin; Daptomycin; Endocarditis; Endocarditis, Bacterial; Fosfomycin; Gentamicins; Microbial Sensitivity Tests; Rabbits | 2020 |
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Salvage Therapy; Standard of Care; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Antimicrobial Photodynamic Inactivation Affects the Antibiotic Susceptibility of
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Combined Modality Therapy; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Plankton | 2021 |
Evaluation of the Antibacterial Efficacy of Daptomycin, Gentamicin, and Calcium Hydroxide-Antibiotic Combinations on
Topics: Anti-Bacterial Agents; Biofilms; Calcium Hydroxide; Daptomycin; Dental Pulp Cavity; Dentin; Enterococcus faecalis; Gentamicins; Root Canal Irrigants | 2021 |
Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Daptomycin; Discitis; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gentamicins; Humans; Italy; Linezolid; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2021 |
Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog® system, a metabolic phenotyping assay.
Topics: Anti-Bacterial Agents; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2022 |